QA108 granules

DRUG2 trials

Sponsors

Smilebiotek Zhuhai Limited

Conditions

Intermediate Age-Related Macular Degeneration

Phase 2

QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration

CompletedNCT05562219

Smilebiotek Zhuhai LimitedIntermediate Age-Related Macular Degeneration

Start: 2022-06-29End: 2024-06-24Updated: 2024-07-15

Phase 3

QA108 Phase III Study in Subjects With Intermediate AMD

RecruitingNCT07189169

Smilebiotek Zhuhai LimitedIntermediate Age-Related Macular Degeneration

Start: 2025-07-08End: 2027-06-30Target: 400Updated: 2025-09-23